Relationship of acute axonal damage, Wallerian degeneration, and clinical disability in multiple sclerosis

被引：0
作者：
Shailender Singh
Tobias Dallenga
Anne Winkler
Shanu Roemer
Brigitte Maruschak
Heike Siebert
Wolfgang Brück
Christine Stadelmann
机构：
[1] University Medical Center,Institute of Neuropathology
[2] Cellular Microbiology,Department of Neurology
[3] Research Center Borstel,undefined
[4] Rigshospitalet,undefined
来源：
Journal of Neuroinflammation | / 14卷
关键词：
Multiple sclerosis; Experimental autoimmune encephalomyelitis; Wallerian degeneration; Axonal damage;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
[41]   Axonal Damage and its Significance for the Concept of Neurodegeneration in Multiple Sclerosis [J].
Recks, M. S. ;
Bader, J. ;
Kaiser, C. C. ;
Schroeter, M. ;
Fink, G. R. ;
Addicks, K. ;
Kuerten, S. .
FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2011, 79 (03) :161-170
[42]   Main Role of Antibodies in Demyelination and Axonal Damage in Multiple Sclerosis [J].
Ursula Muñoz ;
Cristina Sebal ;
Esther Escudero ;
Margaret Esiri ;
John Tzartos ;
Carolyn Sloan ;
Mari Cruz Sadaba .
Cellular and Molecular Neurobiology, 2022, 42 :1809-1827
[43]   Imaging axonal damage in multiple sclerosis by means of MR spectroscopy [J].
N. De Stefano ;
S. Narayanan ;
M. Mortilla ;
L. Guidi ;
M.L. Bartolozzi ;
A. Federico ;
D.L. Arnold .
Neurological Sciences, 2000, 21 (Suppl 2) :S883-S887
[44]   Main Role of Antibodies in Demyelination and Axonal Damage in Multiple Sclerosis [J].
Munoz, Ursula ;
Sebal, Cristina ;
Escudero, Esther ;
Esiri, Margaret ;
Tzartos, John ;
Sloan, Carolyn ;
Sadaba, Mari Cruz .
CELLULAR AND MOLECULAR NEUROBIOLOGY, 2022, 42 (06) :1809-1827
[45]   Biological markers for axonal degeneration in CSF and blood of patients with the first event indicative for multiple sclerosis [J].
Hein , Katharina ;
Koehler, Anushka ;
Diem, Ricarda ;
Saettler, Muriel B. ;
Demmer, Iris ;
Lange, Peter ;
Baehr, Mathias ;
Otto, Markus .
NEUROSCIENCE LETTERS, 2008, 436 (01) :72-76
[46]   Networks of microstructural damage predict disability in multiple sclerosis [J].
Colato, Elisa ;
Prados, Ferran ;
Stutters, Jonathan ;
Bianchi, Alessia ;
Narayanan, Sridar ;
Arnold, Douglas L. ;
Wheeler-Kingshott, Claudia ;
Barkhof, Frederik ;
Ciccarelli, Olga ;
Chard, Declan T. ;
Eshaghi, Arman .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2023, 94 (12) :992-1003
[47]   Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time [J].
Kuhlmann, T ;
Lingfeld, G ;
Bitsch, A ;
Schuchardt, J ;
Brück, W .
BRAIN, 2002, 125 :2202-2212
[48]   Inflammatory responses in Multiple Sclerosis normal-appearing white matter and in non-immune mediated neurological conditions with wallerian axonal degeneration: A comparative study [J].
Vercellino, M. ;
Trebini, C. ;
Capello, E. ;
Mancardi, G. L. ;
Giordana, M. T. ;
Cavalla, P. .
JOURNAL OF NEUROIMMUNOLOGY, 2017, 312 :49-58
[49]   The relationship between cerebellar volume, clinical disability and cognitive changes in multiple sclerosis patients [J].
OZTURK, Onural ;
OZTURK, Seda ;
GUL, Sedat ;
BUNUL, Sena Destan ;
EFENDI, Husnu ;
CAM, Isa .
NEUROLOGY ASIA, 2021, 26 (02) :341-346
[50]   LOTUS, a possible endogenous inhibitor of axonal degeneration, as a new biomarker for multiple sclerosis [J].
Takahashi, Keita ;
Tanaka, Fumiaki ;
Takei, Kohtaro .
NEURODEGENERATIVE DISEASE MANAGEMENT, 2015, 5 (06) :469-472
12345